Ocular Therapeutix (OCUL) PT Raised to $7 at Raymond James As Phase 1 Data Impresses
Tweet Send to a Friend
Raymond James analyst Dane Leone raised the price target on Ocular Therapeutix (NASDAQ: OCUL) to $7.00 (from $5.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
